Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer
Clinical trial NCT06795178 · WITHDRAWN
Trial details
- NCT number
- NCT06795178
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.